Concepedia

Author

Matthieu Chasseray

Institut de Cancérologie de Bourgogne

Also Known As

Chasseray, Matthieu, M. Chasseray, Matthieu Chasseray

11

Publications

86

Citations

5

H-Index

15

Concepts

All Affiliations

Institut de Cancérologie de BourgogneCentre Hospitalier privé Saint GrégoirePfizer (France)Institut Jean GodinotClinique Victor Hugo
MC

About

Matthieu Chasseray is an author at Institut de Cancérologie de Bourgogne specializing in cancer therapeutics, outcomes research, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

34

2

Medicine

2

2

34

3

Cancer Therapeutics

2

2

34

4

Clinical Trials

2

2

34

5

Gynecology Oncology

2

2

34

Matthieu Chasseray

×

4

Publications

75

Citations

4

H-Index

YearCitations

Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment

Philippe Barthélémy, Constance Thibault, Aude Fléchon,

European Urology Oncology

2024

25

Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

Philippe Barthélémy, Yohann Loriot, Constance Thibault,

Journal of Clinical Oncology

2024

20

Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with <sup>125</sup>I low dose rate brachytherapy for localized prostate cancer

Matthieu Chasseray, Gurvan Dissaux, Vincent Bourbonne,

Acta Oncologica

2019

16

Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).

Philippe Barthélémy, Yohann Loriot, Éric Voog,

Journal of Clinical Oncology

2023

14

Page 1